TPB Q4 net sales +12.8% to $93.7M; FY24 adjusted EBITDA +12% to $104.5M

Turning Point Brands, Inc.

Q4 adjusted EBITDA $26.2M (+5.3%), adjusted diluted EPS $0.98 (vs $0.82).
Stoker's segment sales +25.8% to $47.8M driven by Modern Oral growth.
FY25 guidance: adjusted EBITDA $108-113M, Modern Oral sales $60-80M.
Issued $300M senior secured notes due 2032 to repay $250M notes due 2026.
Contributed 100% of Creative Distribution Solutions to a JV for 49% stake (discontinued ops).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.